News & Press Coverage
Latest updates, media appearances, and announcements from Alerje
Featured Coverage
Sempresto Acquires Alerje's Autoinjector Platform
Sempresto acquires Alerje's autoinjector platform to accelerate commercialization of smartphone-integrated rescue medications.
Read moreAll News & Press
Sempresto Acquires Alerje's Autoinjector Platform
Sempresto acquires Alerje's autoinjector platform to accelerate commercialization of smartphone-integrated rescue medications.
Monsha'at Signs MoU with Alerje at Saudi-US Investment Forum
Saudi Arabia's SME authority partners with Alerje to boost innovation in health technologies as part of Vision 2030.
Mitsubishi & Alerje Sign Agreement to Form Strategic Partnership
Mitsubishi Gas Chemical Company and Alerje partner to revolutionize allergy care through innovative technologies.
CES 2024: Medical Technologies You Need to Know
Alerje featured among 4,000+ companies at CES, highlighting innovative digital health technologies.
Alerje Earns $1M Phase II SBIR NSF Award
NSF grant supports life changing food allergy immunotherapy with AI driven FAIT platform.
Illinois State Article: Turning an Allergy into Alerje Inc
Profile on founder Javier Evelyn's journey from personal experience to healthcare innovation.
Alerje Featured in the Free-From Magazine
Food Equality Initiative's Free-From Magazine highlights Alerje's mission to improve food allergy care.
Introducing: The Smart Defenders Comic Series
Illustrated comic series helping children understand food allergies and oral immunotherapy journey.
Detroit Entrepreneur Makes Life Saving Phone Case
Coverage of local healthcare innovation and Alerje's impact on allergy care.
Phase 1 SBIR Grant Award From The National Science Foundation
Initial NSF funding to develop AI powered oral immunotherapy support platform.
Media Inquiries
For press inquiries, interview requests, or additional information about Alerje and FAIT™, please reach out to our team.